Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New phase I data on the safety and pharmacokinetics of PTC-124

April 12, 2005

A novel vasopressin V1b receptor antagonist reduces aggressive behavior

April 12, 2005

New agents for Alzheimer's dementia reported in patent literature

April 11, 2005

Lunesta now available

April 11, 2005

Schwarz Pharma's rotigotine NDA accepted for filing

April 8, 2005

ImaRx studies Sonolysis in phase II stroke study

April 8, 2005

Transdermal methylphenidate shows efficacy in children with ADHD

April 8, 2005

Neuroprotective efficacy of repinotan hydrochloride, a 5-HT1A receptor agonist / News in Context

April 8, 2005

New patents describe therapeutic agents for psychiatric disorders

April 8, 2005

Interleukin-4 mediates inflammatory modulation of synaptic function in the hippocampus

April 8, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...